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Abstract: 
We studied communication in genetic counseling sessions conducted with an African American, Breast Cancer 
1, Early Onset (BRCA1) kindred in the USA. The Roter Interaction Analysis System (RIAS) was used to code 
and compare two sessions of 46 participants (26 females and 20 males) before and after they underwent genetic 
testing. Three certified genetic counselors and one medical geneticist conducted the sessions. When compared 
to pre-test communication, most of the providers’ post-test communication was devoted to the provision of 
biomedical information (including screening recommendations) with fewer questions and psychosocial 
statements. Clients contributed a similar proportion to the total session dialogue in pre- and post-test sessions 
(40%). A larger proportion of their post-test session was devoted to indicating receptiveness to provider 
information than in the pre-test session. We found when providers were informing clients that they were 
BRCA1 mutation carriers, they provided more biomedical and psychosocial information and asked more 
psychosocial questions than when talking with non-carriers. This study provides the first description of genetic 
counseling communication for pre- and post-test BRCA1 sessions with African American individuals. 
Keywords: BRCA1; Communication; African American; Genetic counseling; Roter interaction analysis system; 
USA 
 
Article: 
Introduction 
Although the majority of individuals currently seeking cancer genetic counseling and testing services in the US 
are non-Latino Caucasian women of middle to upper middle class socioeconomic status (Armstrong, Carney, 
Stopfer, & Putt (2005) K.M. Armstrong, A. Carney, J. Stopfer and M. Putt, Racial differences in the use of 
brca1/2 testing among women with a family history of breast or ovarian cancer, Journal of the American 
Medical Association 293 (2005) (14), pp. 1729–1736.    (79)Armstrong, Carney, Stopfer, & Putt, 2005; Hall & 
Olopade, 2005; Hughes et al., 1997), this may not be true in the future. BRCA1/2 mutations have been 
identified in African and African American families, but more research is needed to understand dispersion 
patterns (Olopade et al., 2003). African American women under 40 years of age have a proportionally higher 
incidence of early-onset breast cancer than non-Latino Caucasian women (Johnson, 2002; Nanda et al., 2005). It 
is likely that a proportion of the African American breast cancer incidence is associated with high penetrance 
genes such as BRCA1/2 (Pal, Permuth-Wey, Holtje, & Sutphen, 2004). This statistic, coupled with data 
indicating that African American individuals may be less knowledgeable about genetic testing and are less 
likely to have access to genetic services than non-Latino Caucasians, highlights the importance of studying the 
dynamics of patient-provider communication with African Americans in such genetic settings (Halbert, Kessler, 
& Mitchell, 2005). 
 
The communication between genetic counselors and clients is an understudied area. A charge from leaders in 
the field to open the ―black box‖ of genetic counseling communication has led to a small but growing body of 
research, particularly in the area of cancer genetic counseling (Biesecker & Peters, 2001). Various research 
teams have described the communication associated with counseling sessions just prior to BRCA1 testing 
(Butow & Lobb, 2004; Ellington et al. (2006) and Ellington et al. (2005); Lobb, Butow, Barratt, Meiser, & 
Tucker, 2005; Lobb et al., 2004; Pieterse, van Dulmen, Ausems, Beemer, & Bensing, 2005). Although these 
studies varied in method and design, multiple similarities in communication were found: genetics service 
providers talked more than clients, sessions were largely focused on biomedical as opposed to psychosocial 
topics, and providers asked significantly more questions than clients. All of these projects were conducted with 
individuals of European descent and examine pre-testing sessions only, and thus significant questions remain 
about the nature of the genetic counseling process with underserved ethnic minorities. 
 
This study was undertaken to explore cancer genetic counseling with African Americans who were known to be 
part of a BRCA1 kindred (Olopade et al., 2003) We applied the Roter Interaction Analysis System (RIAS) 
(Roter, 2002) to cancer genetic counseling sessions. RIAS is the most widely used system of interaction 
analysis with demonstrated levels of sensitivity and concurrent validity, and has been used in over 100 studies 
of patient–physician communication (Roter & Larson, 2002). The feasibility and validity of using RIAS with 
genetic counseling sessions has been documented (Ellington et al., 2005). Findings from the application of the 
RIAS offer the potential to develop improved counseling strategies as well as to educate genetic counseling 
students and practitioners (Roter, Ellington, Erby, Larson, & Dudley, in press). Using the RIAS, we 
characterized the nature of communication during sessions both before and after genetic testing and with 
carriers versus non-carriers, in an attempt to highlight variations associated with these variables. 
 
Methods 
Study population 
Study participants were part of a larger investigation of the psychosocial and behavioral effects of BRCA1 
counseling in the US. Participants were members of an African American kindred (K2099), which was 
previously identified as having the BRCA1 mutation during a genetic epidemiologic study conducted to localize 
the BRCA1 gene (Miki et al., 1994). Carrier status was not revealed as part of the original linkage study, as the 
testing was done in a research setting prior to identification of the BRCA1 gene. The parent project and current 
communication study were approved by the Institutional Review Boards at University of Utah and at Louisiana 
State University. 
 
Procedure 
Recruitment for the parent project began in 2001 and long-term follow up continued. Recruitment procedures, 
eligibility criteria, and research protocol have been described in detail elsewhere (Kinney et al., 2005) but are 
summarized here. Using the pedigree from the original linkage study, those individuals who agreed to be 
contacted for possible participation in future studies were sent a letter inviting them to participate in a genetic 
testing and counseling research study. Kindred members were asked to return a form if interested, and were 
then contacted by telephone to complete a screening survey to determine participant eligibility. After consenting 
to the genetic counseling study, participants completed a baseline interview. One hundred and sixty kindred 
members expressed initial interest to participate in the study; of those 105 (65%) completed the baseline 
interview. The baseline-structured interview was conducted by trained study staff and consisted of a large 
battery of questionnaires (e.g., questions targeted sociodemographics, access to clinical genetic services, 
perceived risk, cancer worry, and social support; Kinney et al., 2006b). Following the baseline interview, 
participants were invited to take part in a genetic education session followed by a testing and counseling 
session. These sessions took place within a two- to four-week period following the baseline interview. 
Participants chose either a group education session and private counseling session or private education followed 
by a private counseling session. The genetic counseling medical information was tailored and materials were 
designed with input from African American focus groups as well as from kindred members (Baty, Kinney, & 
Ellis, 2003). Ninety-nine of those completing the baseline interview participated in an education and counseling 
session. Following the counseling session, 87 participants underwent genetic testing, while the remaining 12 
counseled subjects declined genetic testing. 
 
Three certified female genetic counselors and one female doctorally prepared medical geneticist conducted the 
counseling sessions (henceforth called ―genetic service providers‖). All providers were non-Latino Caucasians. 
Assignment of clients to a particular counselor was based on scheduling availability. 
 
The protocols for the pre- and post-test sessions followed current practice standards (Baty et al., 1997). The 
outline for the pre-test education session included information about cancer genes and BRCA1 in general, 
discussion of general population and carrier cancer risks, education about screening and preventive behaviors, 
description of available testing, and an examination of the benefits and disadvantages of genetic testing and 
genotype knowledge. The pre-test counseling session included family and medical histories, screening for 
untreated mental health diagnoses, discussion of current and past personal cancer screening practices, screening 
education, discussion of prior risk and how testing might change risk, explanation of availability of oncology 
consultation, discussion of the testing decision, opportunity for questions and discussion of personal issues (e.g., 
impact of personal and familial cancer experiences), and informed consent if testing was chosen. Participants 
were given a family-specific pamphlet developed for the study and were sent a short follow-up letter. 
Approximately one month after the blood test, a second session was scheduled. Post-test sessions involved 
revealing test results, discussion of immediate reactions to test results, information about personal risk of cancer 
based on the test result, a review of options for surveillance and preventive measures, an explanation of altered 
risks for relatives, referral recommendations, arrangement for a follow-up phone call, and the offer of additional 
counseling sessions by request. A written results letter was sent after the session. Both pre- and post-test 
sessions were audio-taped with permission from the participant. These 1–2 h sessions were scheduled at 
locations convenient to the participants (e.g., local community center, private area in participant's home) and 
were provided at no cost to the participant (Kinney et al., 2006a). 
 
Of the 87 participants that underwent genetic testing, 85 participated in the post-test session and 46 participants’ 
pre- and post-test sessions were coded for use in this study. Because of the restraints of our grant funding 
dedicated to trained coders, we were able to record and code only sessions through the summer of 2003 (n=46) 
The 46 participants included in this study did not differ on any demographic characteristics from the 39 
participants whose sessions were not coded. 
 
Measures 
RIAS coding of genetic counseling sessions: Trained coders applied the RIAS directly from audiotapes, without 
transcription, using direct entry software (Roter, 2002). The unit of analysis for RIAS coding is defined as the 
smallest speech segment that expresses a complete thought. This may be a statement, a phrase, a clause, or a 
single word. Each complete thought is assigned to a mutually exclusive and exhaustive category. Thus, the 
RIAS codes provide a comprehensive accounting of every thought expressed during an interaction by each 
speaker. 
 
For purposes of the current study, coding focused on the following composite categories (example statements 
are presented in Table 1) reflecting dialogue by the genetic service provider and by the client: (1) Biomedical 
information, which includes statements of medical history, information related to breast cancer risk, and 
information regarding the test for the BRCA1 gene mutation; (2) Psychosocial communication, which includes 
the discussion of emotional reactions to genetic testing and self-care information; (3) Question asking, which 
includes all open and closed questions; (4) statements that reflect social chit-chat (e.g., comments about the 
weather); (5) Positive talk, including laughter (statements of approval are counselor only); (6) statements 
showing agreement and/or understanding are labeled as Receptive communication (e.g., uh-huh, right; 
agreement code only). Two more composite categories represent provider-only dialogue. The first is called 
Emotional talk in which the provider makes statements of reassurance, empathy, and concern. Emotional talk 
differs from Psychosocial communication in that the former reflects the affective process inherent in a statement 
and the latter reflects a topic of a psychosocial nature (without an emotional or affective overtone). If a 
statement reflects both psychosocial information and is affectively charged then it would reside in the 
Emotional talk category. The remaining provider composite category is dialogue that reflects the provider's 
attempt to Activate and partner with the client. This composite category includes paraphrasing, orienting 
statements, and back channeling. 
 
Table 1. Examples of session dialogue reflecting RIAS categories  
RIAS composite 
categories 
Statement examples 
Biomedical 
information 
GC: The population risk is …; Smoking has been associated with increased risk; If you 
have what we call a mutation, a change in the DNA, then you may have a higher chance of 
having a tumor start to form. 
 
CT: My sister was diagnosed with cancer last year; I have a mammogram about once a 
year. 
Psychosocial/lifestyle 
communication 
GC: Families often find it helpful to discuss testing; My mother and I were very close. 
 
CT: I don’t want to burden my family; My husband is very supportive. 
Question asking 
GC: Has anyone else in your family been diagnosed with cancer?; How worried are you 
about your sister?; Do you exercise regularly? 
 
CT: Can my daughters get cancer?; What do other people in this situation do?; Do I 
increase my risk by eating fatty foods? 
Social chit-chat GC: Parking here can be a headache; The weather has been chilly lately. 
 
CT: We are avid fans of professional hockey. 
Positive talk GC: You are absolutely right!; (laughter). 
 
CT: You have been very helpful; How interesting! 
Receptive 
communication 
(agreement code only) 
GC: Yes, that's right. 
 
CT: Uh-huh; yes; okay. 
Emotional talk GC: I think you will feel better as time passes; So you are really worried. 
Activating and 
partnering 
GC: Let me make sure I’ve got what you said right…; I would like to review your family 
history first; uh-huh, go-on. 
 
Note. GC=genetic services provider; CT=client. 
 
 
 
Intercoder reliability was calculated between coders based on a set of nine tapes (20%), including both pre- and 
post-sessions. Reliability for the RIAS individual codes was assessed separately for genetic provider and client 
codes. Pearson correlation coefficients for high-frequency categories (codes with a mean frequency of >2 
statements per visit; (Roter & Ewart, 1992; Roter & Larson, 2002) averaged 0.80 (range=0.77−0.99) for genetic 
counselor talk (with a few exceptions) and 0.96 (range=0.77−0.99) for client talk. Two provider codes related to 
Emotional talk (empathy, r=0.43; M=2.58 (2.86) and reassurance, r=−0.08; M=2.88 (2.91)) had low reliability 
coefficients. When these codes were combined with the concern code to create the composite category of 
Emotional talk, the coefficient for the category was acceptable at r=0.71. The low intercoder reliabilities for 
empathy and reassurance likely reflect their low frequency of occurrence (albeit acceptable) and the difficulty 
coders have in differentiating them from the concern code, as they all represent emotionally responsive 
communication. Additionally, the intercoder reliability for approval was low r=0.26; M=5.86 (4.85); however, 
once examined within the composite category of Positive talk, the coefficient was acceptable. Reliabilities for 
all composite code variables averaged over 0.90 (range=0.71–0.99). The composite categories account for the 
majority of session communications and are used in subsequent analyses, but those that consist of codes with 
low intercoder reliability have been interpreted with caution. 
 
Analysis 
All analyses were conducted using SPSS version 13.0 (SPSS, 2005). Descriptive statistics were used to examine 
the communication within the genetic sessions along the coding categories present in Table 1. Differences 
between the communication of pre- versus post-test sessions and post-test sessions for carriers versus non-
carriers were assessed by t-tests. Two-tailed p values <0.05 were considered statistically significant. 
 
Results 
Characteristics of study population 
Forty-six individuals (n=26 females; n=20 males) from the parent project make up the participants in the 
present study. All participants self-identified as African American and 89.1% (n=41) also identified themselves 
as Black Creole (Dubois & Melancon, 2000). Most participants were married or living as married (82.6%; 
n=38) and were high school graduates or had completed a higher level of education (82.6%; n=38). Nearly two 
thirds of the participants (60.9%; n=28) had an annual income greater than $30,000 per year, and 69.6% (n=32) 
had private health insurance. Seventeen percent (17.4%; n=8) of the participants were found to be BRCA1 
mutation carriers. 
 
Pre-test communication 
As seen in Table 2, a large portion of the communication in the pre-test session was biomedically focused with 
fewer statements or questions of a psychosocial nature. Genetic service providers contributed 59% of the total 
talk at the pre-test sessions. Also, a relatively large proportion of genetic provider dialogue was devoted to 
question asking. These questions were predominantly of a biomedical nature. Roughly the same proportion of 
provider talk was devoted to Activating and partnering and statements showing understanding and agreement. 
Emotional talk comprised a small portion of provider talk. 
 
 
 
Table 2. Comparison of pre- and post-test communication  
  
Pre-test  
 
Post-test  
 
  
Genetic 
counselor 
Client 
Genetic 
counselor 
Client 
Biomedical information % 0.2447 0.4880 0.5106  0.2624  
 
Mean frequency 
(SD) 
106.91 
(123.00) 
134.46 
(73.51) 
150.33 
(132.74) 
48.59 
(33.06) 
 
Range 8–742 23–321 17–675 5–143 
Psychosocial/lifestyle 
communication 
% 0.014 0.1680 0.0236 0.0831  
 
Mean frequency 
(SD) 
8.89 (9.63) 46.63 (44.96) 7.67 (9.94) 
17.26 
(26.93) 
 
Range 0–35 0–290 0–41 0–155 
Question asking (total) % 0.2601 
 
0.0622  
 
 
Mean frequency 
(SD) 
81.63 (30.82) — 15.67 (11.11) — 
 
Range 23–160 0.0106 2–52 .0175 
Biomedical questions % 0.1925 3.43 (3.87) 0.0449  3.57 (4.81) 
 
Mean frequency 
(SD) 
62.52 (28.27) 0–17 11.46 (10.33) 0–20 
 
Range 15–139 — 1–52 — 
Psychosocial questions % 0.0542 
 
0.0188  
 
 
Mean frequency 
(SD) 
16.35 (7.70) 
 
4.96 (4.65) 
 
  
Pre-test  
 
Post-test  
 
  
Genetic 
counselor 
Client 
Genetic 
counselor 
Client 
 
Range 0–40 
 
0–19 
 
Social chit-chat % 0.0140 0.0157 0.0281 0.0455  
 
Mean frequency 
(SD) 
4.96 (8.43) 5.93 (13.26) 7.46 (12.34) 
10.43 
(24.94) 
 
Range 0–38 0–78 0–58 0–120 
Positive talk % 0.0567 0.0625 0.0657 0.0683 
 
Mean frequency 
(SD) 
20.87 (17.76) 18.80 (16.96) 18.59 (13.72) 
14.15 
(13.76) 
 
Range 1–80 0–81 0–53 0–54 
Receptive communication 
(agreements) 
% 0.1466 0.1806 0.0840  0.4643  
 
Mean frequency 
(SD) 
51.76 (30.21) 55.96 (52.74) 22.04 (13.56) 
97.46 
(94.48) 
 
Range 8–121 2–208 2–62 3–458 
Emotional talk % 0.0243 
 
0.0496  
 
 
Mean frequency 
(SD) 
8.49 (5.95) — 10.30 (5.53) — 
 
Range 0–30 
 
1–30 
 
Activating and partnering % 0.1630 
 
0.0941  
 
 
Mean frequency 
(SD) 
54.41 (33.89) — 24.41 (28.07) — 
 
Range 7–152 
 
4–185 
 
 
Note. A single dash indicates that the mean frequency of respective RIAS code was< 2. A double dash indicates 
that it is not a coded category for the speaker. The percent symbol (%) indicates the average composite 
statements as a percent of the total speaker statements. Mean frequency represents the mean number of 
statements by the speaker. 
 p<.05.  
 
 
 
Clients contributed 41% of the total talk at the pre-test session. Similar to the provider, a majority of client 
communication was devoted to the provision of Biomedical information with less devoted to the provision of 
psychosocial information. Clients asked relatively few questions during the pre-test session. Nearly a fifth of 
client talk was statements such as ―yes‖ and ―uh-huh‖. 
 
Post-test communication 
Post-test communication is also presented in Table 2. Note that most of genetic service providers’ 
communication was biomedical in nature with relatively fewer psychosocial statements. A similar proportion of 
genetic provider post-test communication was devoted to each of the following categories: Emotional talk, 
Activating and partnering, question asking, and statements reflecting agreement and understanding. 
Similar to the pre-test ratio, clients contributed 40% of the total post-test session talk. Nearly half of client 
participation reflects statements of agreement and understanding. Client statements related to Biomedical 
information comprised a quarter of their post-test dialogue, with fewer psychosocial statements. As with the 
pre-test sessions, client post-test session communication showed minimal question asking. 
 
Comparison of pre-/post-test communication 
We found that pre- and post-test communication differed significantly for both client and provider. Providers 
asked proportionally more questions in the pre-test session than in the post-test session, t(90)=14.30, p<0.05 and 
they expressed more Activating and partnering statements than in the post-test session, t(90)=4.67, p<0.05. 
Providers devoted a greater proportion of their post-test session dialogue to Biomedical information than in pre-
test sessions, t(90)=10.23, p<0.05. Moreover, they exhibited proportionally more Emotional talk in post-test 
sessions than in pre-test sessions, t(90)=4.79, p<0.05. 
 
In contrast to the genetic service provider findings, we found proportionally less client Biomedical information 
in post-test sessions than in pre-test sessions, t(90)=8.96, p<0.05, and less psychosocial talk, t(90)=4.59, p<0.05. 
Clients also expressed more Receptive communication in the post-test sessions when compared with pre-test 
sessions, t(90)=9.66, p<0.05. 
 
Post-test communication by carrier status 
As can be seen in Table 3, in post-test sessions with BRCA1 mutation carriers, providers dedicated significantly 
more of their talk to both Biomedical information and Psychosocial communication, t(44)=3.07, p<0.05, than in 
post-test session with non-carriers. Providers also asked more psychosocial questions of carriers than non-
carriers, t(44)=3.30, p<0.05 and expressed more Activating and partnering statements to non-carriers than 
carriers. Providers dedicated more of their communication to positive talk and statements of agreement and 
understanding to non-carriers than carriers. There were no differences in client post-test communication by 
carrier status. 
 
 
Table 3. Comparison of communication for carriers and non-carries during the session after genetic testing  
  
BRCA1 carriers N=8  
 
Not Carriers N=38  
 
  
Genetic 
counselor 
Client 
Genetic 
counselor 
Client 
Biomedical information % 0.6187  0.1981 0.4879 0.2759 
 
Mean frequency 
(SD) 
272.50 
(176.04) 
46.88 (30.97) 
124.61 
(107.98) 
48.95 
(33.86) 
 
Range 83–576 10–87 17–675 5–143 
Psychosocial/lifestyle 
communication 
% 0.0472  0.1195 0.0186 .0755 
 
Mean frequency 
(SD) 
19.00 (11.88) 18.63 (7.69) 5.29 (7.75) 
16.97 
(29.50) 
 
Range 3–34 6–32 0–41 0–155 
Question asking (total) % 0.0579 — 0.0630 — 
 
Mean frequency 
(SD) 
22.13 (10.45) 0.0215 14.32 (10.89) 0.0166 
 
Range 8–43 6.75 (7.74) 2–52 2.89 (3.75) 
Biomedical questions % 0.0356 0–20 0.0468 0–16 
 
Mean frequency 
(SD) 
14.38 (8.47) — 10.84 (10.68) — 
 
Range 4–32 
 
1–52 
 
Psychosocial questions % 0.0365  
 
0.0150 
 
 
Mean frequency 12.50 (4.14) 
 
3.37 (2.86) 
 
  
BRCA1 carriers N=8  
 
Not Carriers N=38  
 
  
Genetic 
counselor 
Client 
Genetic 
counselor 
Client 
(SD) 
 
Range 6–19 
 
0–12 
 
Social chit-chat % 0.0058  0.0096 0.0328 0.0531 
 
Mean frequency 
(SD) 
1.75 (4.17) 2.75 (5.75) 8.66 (13.17) 
12.05 
(27.10) 
 
Range 0–12 0–16 0–58 0–120 
Positive talk % 0.0392  0.0588 0.0712 0.0702 
 
Mean frequency 
(SD) 
17.50 (12.93) 14.63 (12.88) 18.82 (14.04) 
14.05 
(14.10) 
 
Range 0–36 1–33 0–53 0–54 
Receptive statements (agreements) % 0.0541  0.5566 0.0903 0.4448 
 
Mean frequency 
(SD) 
20.75 (11.15) 
190.88 
(173.31) 
22.32 (14.13) 
77.79 
(53.76) 
 
Range 10–43 3–458 2–62 8–232 
Emotional talk % .0394 — 0.0518 — 
 
Mean frequency 
(SD) 
13.38 (7.44) 
 
9.66 (4.93) 
 
 
Range 5–30 
 
1–23 
 
Activating and partnering % 0.0536  –– 0.1026 — 
 
Mean frequency 
(SD) 
20.75 (10.11) 
 
25.18 (30.59) 
 
 
Range 8–33 
 
4–185 
 
 
Note. A single dash indicates that the mean frequency of respective RIAS code was <2. A double dash indicates 
that it is not a coded category for the speaker The percent symbol (%) indicates the average composite 
statements as a percent of the total speaker statements. Mean frequency represents the mean number of 
statements by the speaker. 
 p<.05  
 
Discussion 
There is a small but growing body of literature on genetic counseling communication, particularly in cancer 
genetics (Butow & Lobb 2004; Roter et al., in press; Ellington et al. (2006) and Ellington et al. (2005); Lobb, 
Butow, Barratt, Meiser, & Tucker (2005) and Lobb et al. (2004); Pieterse, van Dulmen, Ausems et al., 2005; 
Pieterse, van Dulmen, Beemer, Ausems, & Bensing, 2005). These initial projects have examined the 
communication of clients of European descent and have assessed only pre-test sessions. The current study offers 
two novel contributions to this body of literature. First, we describe cancer genetic counseling communication 
for sessions with African American individuals at familial risk. Second, we provide an examination of post-test 
communication and how the dialogue may vary from pre- to post-sessions and for carriers and non-carriers. 
 
Consistent with previous research conducted on non-Latino Caucasians, we found that the communication in 
cancer genetic counseling pre-test sessions tends to be largely biomedical in nature with significantly less talk 
devoted to psychosocial issues (Ellington et al., 2005; Lobb et al., 2004; Pieterse, van Dulmen, Ausems et al., 
2005). Some differences from previous findings are evident, such as more provider talk of an emotional nature. 
When compared to Pieterse et al.'s work (Pieterse, van Dulmen, Beemer et al., 2005), the participants in the 
present study asked fewer questions, but discussed more psychosocial issues. These findings may reflect the 
fact that these sessions were part of a larger study with frequent communication concerning the project as a 
whole, and a pre-test education session (Kinney et al. (2005), Kinney et al. (2006a) and Kinney et al. (2006b)). 
Thus, one explanation for fewer questions is that clients already felt well informed. An alternative explanation 
is the racial and socio-economic power asymmetry between the providers and the clients (Cooper et al., 2003). 
A key purpose of the pre-test session is to promote informed decision making about testing and thus the 
predominant focus of previous research has been on the communication during these initial sessions. As one 
reviewer of this manuscript noted, the pre-test sessions tended to have more of routine format involving 
biomedical information than post-test sessions. For example, a large portion of the pre-test session is devoted to 
family and medical history taking and the dialogue structure is turn taking (i.e., the genetics services providers 
asks a question about family history and the client provides an answer). The post-test session is equally 
important, complex and delicate, particularly for individuals at familial risk for cancer. Counselors must convey 
test results including lay explanations of test specificity and sensitivity, discuss screening recommendations 
based on carrier status, discuss subsequent results disclosure with family members, and assess the potential 
emotional reactions of clients (e.g., relief, guilt, disappointment, fear, and anxiety). Our findings suggest that 
providers are equally emotionally responsive in the pre-test and in the post-test sessions. 
 
We found that post-test communication was more consistent with some aspects of a provider-driven educational 
approach than the pre-test sessions. More of the genetic services providers’ post-test communication was 
devoted to the provision of Biomedical information (including screening recommendations) with fewer 
questions and psychosocial statements than in the pre-test. The pre- and post-test differences in proportion of 
talk devoted to Biomedical information may be explained in part by the separate educational session held prior 
to the pre-test counseling session. A combined education and counseling pre-test session is the most common 
mode of practice and thus the generalizability of our findings are limited somewhat by this ―extra‖ session. The 
benefits of a combined versus separate pre-testing session remain a relevant empirical and clinical question. 
 
As one would expect, the clients devoted a significant portion of the pre-test session providing Biomedical 
information (including family history). Conversely, the majority of what the client said in the post-test sessions 
were comments indicating that they were receiving a large amount of information and agreeing with what was 
being said (e.g., ―uh-huh, yes‖). Among a Caucasian population, this client verbal behavior has been interpreted 
by investigators as a sign of passive listening or passive learning which may result in reduced understanding for 
the counselee as compared to a more interactive discussion (Butow & Lobb, 2004). Another explanation for a 
large percentage of client post-session agreement-type statements may be specific to this ethnic group. The 
consistent, almost rhythmic murmuring of ―uh-huh,‖ ―yeah,‖ ―hmm,‖ is common in African American 
interpersonal exchanges and is referred to as back channeling (Green, 2002). Back channeling indicates that the 
listener is encouraging the speaker to continue and is ―in tune‖ with what the speaker is saying. The specific 
RIAS back channel code reflects attentiveness and is a ―provider-only‖ code which has been the topic of some 
controversy in the literature (see Roter & Larson, 2002; Sandvik et al., 2002). Thus, in the present study the 
RIAS code for agreement was used for client utterances such as ―uh-huh‖ and to some extent may reflect active 
engagement rather than passive listening. 
 
Of additional note, in contrast to the pre-test sessions, there was a significant reduction in the post-test session 
of counselor statements reflecting partnership and activation. These communication skills are important in trust 
building with clients and helping them make informed decisions (Jenkins, Fallowfield, Souhami, & Sawtell, 
1999). Research from Hall and colleagues (Hall, Roter, & Katz, 1988) suggests that these skills are equally 
important in promoting adherence to provider recommendations. The post-test session provides a critical 
opportunity for counselors to introduce and/or reinforce breast and ovarian cancer screening practices among 
carriers and non-carriers alike. Using communication strategies that are known to increase adherence is 
important in the clinical setting, particularly with African American clients who as a group tend to have low 
cancer screening practices (Crump, Mayberry, Taylor, Barefield, & Thomas, 2000). 
 
Another verbal strategy to promote screening among clients besides Activate and partner statements may be 
what Sarangi and colleagues (Sarangi et al., 2004) call a ―reflective frame.‖ According to these investigators, 
reflective frames are provider questions that elicit client introspection about a decision-making process and 
subsequent consequences. The RIAS does not include this code, so we were unable to ascertain if a subset of 
provider psychosocial questions are consistent with reflective frames. 
 
We found when providers were informing clients that they were BRCA1 mutation carriers, they provided more 
Biomedical information (which includes screening recommendations), Psychosocial communication (which 
includes discussion of results with family members) and asked more psychosocial questions than when they 
talking with non-carriers. Additionally, as one would expect, providers appeared to be using a more ―down to 
business‖ communication approach with carriers than non-carriers (e.g., less laughter and social chit-chat). Our 
findings for post-test communication with carriers are consistent with sociolinguistic investigations of genetic 
counseling (Benkendorf, Prince, Rose, DeFina, & Hamilton, 2001). Genetic service providers are likely to feel 
most comfortable coming from a position of ―medical expert‖ when delivering information that is likely to 
invoke fear and a feeling of vulnerability among clients. This is reflected in provider style focused on imparting 
biomedical information in an educational-type format, which reflects sociolinguistic concepts of differential 
power and social distance in interpersonal encounters (Brown & Levinson, 1987). Further research is warranted 
to understand how this interpersonal positioning influences genetic counseling client outcomes, particularly 
when the provider is from the dominant culture and the client is from a minority culture. More research is also 
needed to determine why clients with carrier status did not differ in their communication compared to those 
with non-carrier status. 
 
Limitations 
A limitation of this study is our small sample size, which resulted in limited power. Thus, we were precluded 
from statistically examining linkages between the communication variables and client characteristics and 
outcomes. Second, with only four genetic service providers, we cannot be certain that the communication 
behaviors are generalizable in nature. Third, the African American kindred participating in this study may not 
be representative of African Americans in the US (Kinney et al., 2005). Many members of this kindred resided 
in rural Louisiana and most family members described themselves as Creole. Fourth, all genetic service 
providers were of European Caucasian ancestry, while all study participants were of African ancestry. Since 
there are known to be differences in communication depending on whether the provider is of the same ethnicity 
as the consumer (Cooper et al., 2003), this also limits the generalizability of our findings. Finally, because the 
counseling sessions were part of a research study, aspects of the research protocol (e.g., baseline interview) may 
have affected the genetic counseling exchange. 
 
Despite these limitations, the current study found important pre-post testing differences in provider 
communication with carrier and non carrier clients that will be useful in designing protocols for counseling of 
African American. 
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